These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
507 related articles for article (PubMed ID: 22476817)
1. Short-term results and long-term oncologic outcomes between neoadjuvant chemoradiotherapy and adjuvant postoperative chemoradiotherapy for stage III rectal cancer: a case-matched study. Kang J; Jang SM; Baek JH; Lee WS; Cho TH Ann Surg Oncol; 2012 Aug; 19(8):2494-9. PubMed ID: 22476817 [TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study. Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580 [TBL] [Abstract][Full Text] [Related]
3. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis. Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992 [TBL] [Abstract][Full Text] [Related]
4. Combined modality therapy for rectal cancer: the relative value of posttreatment versus pretreatment CEA as a prognostic marker for disease recurrence. Song S; Hong JC; McDonnell SE; Koong AC; Minsky BD; Chang DT; Liauw SL Ann Surg Oncol; 2012 Aug; 19(8):2471-6. PubMed ID: 22327251 [TBL] [Abstract][Full Text] [Related]
5. Is adjuvant chemotherapy really needed after curative surgery for rectal cancer patients who are node-negative after neoadjuvant chemoradiotherapy? Kiran RP; Kirat HT; Burgess AN; Nisar PJ; Kalady MF; Lavery IC Ann Surg Oncol; 2012 Apr; 19(4):1206-12. PubMed ID: 21935748 [TBL] [Abstract][Full Text] [Related]
6. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival. Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629 [TBL] [Abstract][Full Text] [Related]
7. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy. Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523 [TBL] [Abstract][Full Text] [Related]
8. Less than 12 nodes in the surgical specimen after total mesorectal excision following neoadjuvant chemoradiation: it means more than you think! de Campos-Lobato LF; Stocchi L; de Sousa JB; Buta M; Lavery IC; Fazio VW; Dietz DW; Kalady MF Ann Surg Oncol; 2013 Oct; 20(11):3398-406. PubMed ID: 23812804 [TBL] [Abstract][Full Text] [Related]
9. Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome. Wolthuis AM; Penninckx F; Haustermans K; De Hertogh G; Fieuws S; Van Cutsem E; D'Hoore A Ann Surg Oncol; 2012 Sep; 19(9):2833-41. PubMed ID: 22451236 [TBL] [Abstract][Full Text] [Related]
10. Randomized trial of postoperative adjuvant therapy in Stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: 10-year follow-up. Kim TW; Lee JH; Lee JH; Ahn JH; Kang YK; Lee KH; Yu CS; Kim JH; Ahn SD; Kim WK; Kim JC; Lee JS Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1025-31. PubMed ID: 20932669 [TBL] [Abstract][Full Text] [Related]
11. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment? Lombardi R; Cuicchi D; Pinto C; Di Fabio F; Iacopino B; Neri S; Tardio ML; Ceccarelli C; Lecce F; Ugolini G; Pini S; Di Tullio P; Taffurelli M; Minni F; Martoni A; Cola B Ann Surg Oncol; 2010 Mar; 17(3):838-45. PubMed ID: 20012700 [TBL] [Abstract][Full Text] [Related]
12. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy. Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608 [TBL] [Abstract][Full Text] [Related]
13. Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis. Shin US; Yu CS; Kim JH; Kim TW; Lim SB; Yoon SN; Yoon YS; Kim CW; Kim JC Ann Surg Oncol; 2011 Aug; 18(8):2232-9. PubMed ID: 21347780 [TBL] [Abstract][Full Text] [Related]
14. Effect of long interval between hyperthermochemoradiation therapy and surgery for rectal cancer on apoptosis, proliferation and tumor response. Kato T; Fujii T; Ide M; Takada T; Sutoh T; Morita H; Yajima R; Yamaguchi S; Tsutsumi S; Asao T; Oyama T; Kuwano H Anticancer Res; 2014 Jun; 34(6):3141-6. PubMed ID: 24922685 [TBL] [Abstract][Full Text] [Related]
15. Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy. Pacelli F; Tortorelli AP; Rosa F; Bossola M; Sanchez AM; Papa V; Valentini V; Doglietto GB Ann Surg Oncol; 2010 Jan; 17(1):152-62. PubMed ID: 19834766 [TBL] [Abstract][Full Text] [Related]
16. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy]. You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061 [TBL] [Abstract][Full Text] [Related]
17. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer]. Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307 [No Abstract] [Full Text] [Related]
18. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study. Madbouly KM; Abbas KS; Hussein AM Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666 [TBL] [Abstract][Full Text] [Related]
19. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy]. Thomschke D; Kyau-Ummen B; Halbfass HJ Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499 [TBL] [Abstract][Full Text] [Related]
20. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer]. Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]